The Spectra Optia(R) Apheresis System from Terumo Blood and Cell Technologies in combination with UVA PIT system can now be used to provide extracorporeal photopheresis immunotherapy The company is ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced today that the Spectra Optia system mononuclear cell (MNC) collection protocol is now cleared by the U.S. Food and Drug Administration (FDA) and ...
Terumo's Spectra Optia® Apheresis System Terumo's Spectra Optia® Apheresis System LAKEWOOD, Colo., U.S., and SANTA ROSA, Calif., U.S., July 27, 2022 (GLOBE NEWSWIRE) -- Acute kidney injury (AKI) and ...
Terumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia(R) Apheresis System at major conferences Lakewood, Colorado, US, May 25, 2023 – Terumo Blood and ...
The Agency believes that the ability to manage the cytokine storm associated with COVID-19 may decrease patient morbidity. The Food and Drug Administration (FDA) has issued an Emergency Use ...
SYDNEY, AUSTRALIA--(Marketwired - Dec 5, 2014) - Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company") announces several enhancements to its CVac manufacturing and logistics ...
LAKEWOOD, Colo., U.S., and SANTA ROSA, Calif., U.S., July 27, 2022 (GLOBE NEWSWIRE) -- Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with ...
The Agency believes that the ability to manage the cytokine storm associated with COVID-19 may decrease patient morbidity. The Food and Drug Administration (FDA) has issued an Emergency Use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback